Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial

Published:2012-04 Issue: Volume:30 Page:A44-A51
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Madhi S.A.,Kirsten M.,Louw C.,Bos P.,Aspinall S.,Bouckenooghe A.,Neuzil K.M.,Steele A.D.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference31 articles.

1. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis;Tate;Lancet Infect Dis,2012

2. Meeting of the immunization Strategic Advisory Group of Experts, April 2009—conclusions and recommendations;Wkly Epidemiol Rec,2009

3. Effect of human rotavirus vaccine on severe diarrhea in African infants;Madhi;N Engl J Med,2010

4. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial;Armah;Lancet,2010

5. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis;Ruiz-Palacios;N Engl J Med,2006

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abundance of Selected Lipopolysaccharide-Rich Bacteria and Levels of Toll-like Receptor 4 and Interleukin 8 Expression Are Significantly Associated with Live Attenuated Rotavirus Vaccine Shedding among South African Infants;Vaccines;2024-03-05

2. Correlates of immune protection against human rotaviruses: natural infection and vaccination;Archives of Virology;2024-03

3. Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC® (frozen formulation) in healthy infants;Human Vaccines & Immunotherapeutics;2023-11-15

4. Vaccine Take of RV3-BB Rotavirus Vaccine Observed in Indonesian Infants Regardless of HBGA Status;The Journal of Infectious Diseases;2023-08-18

5. Rotavirus vaccination as a public health strategy to reduce the burden of hospitalization: The field experience of Italy (2008−2018);Journal of Medical Virology;2023-07-29